Marcus Chapman - Net Worth and Insider Trading
Marcus Chapman Net Worth
The estimated net worth of Marcus Chapman is at least $9,030 dollars as of 2024-09-20. Marcus Chapman is the See Remarks of Seres Therapeutics Inc and owns about 8,600 shares of Seres Therapeutics Inc (MCRB) stock worth over $9,030. Details can be seen in Marcus Chapman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marcus Chapman has not made any transactions after 2019-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marcus Chapman
Marcus Chapman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marcus Chapman owns 1 companies in total, including Seres Therapeutics Inc (MCRB) .
Click here to see the complete history of Marcus Chapman’s form 4 insider trades.
Insider Ownership Summary of Marcus Chapman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2019-11-22 | See Remarks |
Marcus Chapman Latest Holdings Summary
Marcus Chapman currently owns a total of 1 stock. Marcus Chapman owns 8,600 shares of Seres Therapeutics Inc (MCRB) as of November 22, 2019, with a value of $9,030.
Latest Holdings of Marcus Chapman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2019-11-22 | 8,600 | 1.05 | 9,030 |
Holding Weightings of Marcus Chapman
Marcus Chapman Form 4 Trading Tracker
According to the SEC Form 4 filings, Marcus Chapman has made a total of 1 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 3,400 shares on November 22, 2019, which brought Marcus Chapman around $13,294.
Insider Trading History of Marcus Chapman
- 1
Marcus Chapman Trading Performance
Marcus Chapman Ownership Network
Marcus Chapman Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Marcus Chapman is the See Remarks of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Marcus Chapman made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 32,192 shares made by Teresa L. Young , a net sale of 18,332 shares made by David S. Ege , and a net sale of 25,054 shares made by Eric D. Shaff .
In summary, during the past 3 months, insiders sold 31,623 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,623 shares. During the past 18 months, 116,712 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,712 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Marcus Chapman Mailing Address
Above is the net worth, insider trading, and ownership report for Marcus Chapman. You might contact Marcus Chapman via mailing address: C/o Seres Therapeutics, Inc., 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
